Virupaksha Organics Limited IPO
Virupaksha Organics Limited IPO
Mainboard NSE & BSE 100% Book Built Offer

Business Overview

Virupaksha is an R&D-driven Indian pharmaceutical company engaged in the manufacture of active pharmaceutical ingredients (APIs) and intermediates. The Company operates across small molecule APIs, intermediates and key starting materials, and also undertakes contract development and manufacturing (CDMO) services by leveraging its research and manufacturing capabilities for third-party clients. As of March 31, 2025, its diversified portfolio comprised 54 products, including 23 APIs and 31 intermediates.

Virupaksha IPO Size

Fresh Issue
₹740 Cr (TBA Shares)

Objects of Issue

  1. Funding capital expenditure requirement for capacity expansion at the Expansion Units
  2. Prepayment &/or repayment of all or a portion of certain outstanding borrowings availed by the Company
  3. General corporate purposes

Virupaksha IPO Financial Performance

(Rs. in crores)

Financial Performance Metrics for Virupaksha IPO
Particulars Mar-25 Mar-24 Mar-23
Revenue 811.71 765.99 644.84
PAT 78.71 73.68 43.09
Net Worth 456.62 275.31 209.71
Borrowings 282.23 264.35 240.85
Assets 952.48 696.69 601.76
NAV (₹) 111.31 73.52 168.04
EPS (₹) 13.17 13.12 7.67

Key Performance Indicators (KPIs)

EBITDA

17.77%

PAT

9.70%

ROE

21.51%

ROCE

19.12%

Debt to Equity

0.58

  • All the data pertains to FY 2024-25.
  • PE, PB, and market capitalization are calculated based on the Upper Price Band.

Promoter Holding

Promoter

59.86%

Public

40.14%

Chandra Gangavaram 9.14%
Vedavathi Gangavaram 17.25%
Gangavaram Lakshmi 9.98%
G Sri Vidya 9.49%
Others 14.00%

Management

Chandra Gangavaram
MD
Kondapalli Reddy
CEO
Prasad Battinapatla
CFO

Registrar & Lead Managers

Company Details

Name: Virupaksha Organics Limited

Address: Plot No. B1 & B2, IDA Gandhinagar, Kukatpally, Medchal, Malkajgiri District, Hyderabad – 500 037 Telangana, India

Number: + 91 40 2307 5816

Email: cs@virupaksha.com

Website: https://virupaksha.com

Explore More IPOs

Discover other active and upcoming IPOs.

Delete Comment?

Are you sure you want to delete this comment? This action cannot be undone.

Discussion

No comments yet. Be the first to share your thoughts!